FIELD: medicine. SUBSTANCE: invention relates to preparation used for treatment of patient with hepatitis. Invention proposes the developed therapeutic composition including human α--interferon, glutathione or its precursor and inducing agent also. Invention proposes also the developed interferon-base pharmaceutical preparations that can be used for treatment of patients with hepatitis B or hepatitis C. EFFECT: broadened arsenal of agents for control of viral infections. 15 cl, 1 tbl, 4 dwg, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF HEPATITIS B TREATMENT | 1992 |
|
RU2104700C1 |
| METHOD OF HEPATITIS TREATMENT, COMPOSITION ENHANCING INACTIVATION OF HEPATITIS C VIRUS IN VIVO, PREPARATION FOR HEPATITIS C TREATMENT | 1992 |
|
RU2104010C1 |
| ENANTIOMERIC COMPOUNDS AND PHARMACEUTICAL COMPOSITION BASED ON THEREOF | 1992 |
|
RU2091386C1 |
| METHOD OF SYNTHESIS OF ENANTIOMERIC COMPOUNDS OR THEIR DERIVATIVES | 1990 |
|
RU2068849C1 |
| METHOD OF TREATING ACUTE VIRAL HEPATITIS B AND MIXED HEPATITIS (B + C, B + D, B + C + D) | 2010 |
|
RU2446798C2 |
| METHOD OF COMPLEX PATHOGENETIC THERAPY OF ACUTE FORMS OF VIRAL HEPATITIS B AND MIXED HEPATITES (B+C, B+D, B+C+D) | 2010 |
|
RU2440128C1 |
| PHARMACEUTICAL HEPATOPROTECTIVE COMPOSITION AND TREATMENT METHOD | 2008 |
|
RU2391989C2 |
| METHOD FOR PREDICTING THE RESULTS OF TREATING PATIENTS WITH CHRONIC HEPATITIS C WITH INTERFERON-ALPHA PREPARATIONS | 2005 |
|
RU2287825C1 |
| METHOD OF INHIBITION OF HEPATITIS B VIRAL INFECTIONS | 1992 |
|
RU2116789C1 |
| METHODS AND PREPARATIONS FOR TREATMENT OF PATIENTS WITH INTERFERON EXHIBITING DECREASED ADVERSE EFFECTS | 1993 |
|
RU2128056C1 |
